Friday, November 22, 2024
HomeTagsPancreatic Cancer

Pancreatic Cancer

Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, announced that it has entered into a preliminary collaboration with the Global...

Aitia Enters into Multi-Year AI-Driven Drug Discovery and Drug Simulation Collaboration with Servier for Pancreatic Cancer

Aitia, the leader in the development and application of Causal AI and "Digital Twins" to discover and develop new drugs, announced a collaboration with...

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative drug discovery platform, announced that the...

Oncolytics Biotech Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer

Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics